Upregulation of ITGBL1 predicted poor prognosis and promoted chemoresistance in ovarian cancer [54] and activated fibroblasts using extracellular vesicles (EVs) via NF-κB signalling. Here, NFKB1 is linked to ovarian carcinoma.